NEW YORK (360Dx) – Klaris Diagnostics today announced the completion of a $3.75 million Series A financing round to support continued development of its rapid antibiotic susceptibility testing platform.
The financing was led by Omnimed Capital.
To read the full story....
Register for Free....and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.